PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Cell. Author manuscript; available in PMC Apr 28, 2012.
Published in final edited form as:
PMCID: PMC3228268
NIHMSID: NIHMS335497
Endothelial-derived inductive angiocrine signals initiate and sustain regenerative lung alveolarization
Bi-Sen Ding,1 Daniel J. Nolan,1 Peipei Guo,1 Alexander O. Babazadeh,1 Zhongwei Cao,1 Zev Rosenwaks,2 Ronald G Crystal,1 Michael Simons,3 Thomas N. Sato,4 Stefan Worgall,1 Koji Shido,1 Sina Y. Rabbany,1,5 and Shahin Rafii1*
1Howard Hughes Medical Institute, Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065
2Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical College, New York, NY 10065
3Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, 06510
4Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Nara, Japan
5Bioengineering Program, Hofstra University, Hempstead, NY 11549
*Correspondence: srafii/at/med.cornell.edu
To identify the pathways involved in adult lung regeneration, we have employed left unilateral pneumonectomy (PNX) model that promotes regenerative alveolarization in the remaining intact right lung lobes. Here, we show that PNX stimulates pulmonary capillary endothelial cells (PCECs) to produce paracrine (angiocrine) growth factors that induce proliferation of epithelial progenitor cells supporting alveologenesis. After PNX, endothelial-specific inducible genetic ablation of Vegfr2 and Fgfr1 in mice inhibited production of MMP14 impairing alveolarization. MMP14 via unmasking cryptic EGF-like ectodomain and activation of EGF-receptor (EGFR) expands epithelial progenitor cells. Neutralization of MMP14 impaired EGFR-ligand mediated alveolar regeneration. By contrast, administration of recombinant EGF, or intravascular transplantation of MMP14+ PCECs from wild-type mice, into pneumonectomized Vegfr2/Fgfr1 deficient mice restored alveologenesis and lung inspiratory volume and compliance function. This study shows that VEGFR2 and FGFR1 activation in PCECs by increasing MMP14-dependent bioavailability of EGFR-ligands initiates and sustains alveologenesis and holds promise to develop therapeutic strategies to promote lung regeneration.
Defining the cellular and molecular mechanisms that modulate adult lung regeneration is essential to develop strategies to treat respiratory disorders (Beers and Morrisey, 2011; Chapman, 2011; Metzger et al., 2008; Morrisey and Hogan, 2010; Sheppard, 2003; Warburton et al., 2010; Whitsett et al., 2010). To identify the regulatory mechanisms involved in adult lung regeneration, we employed a model in which surgical removal of the left lung, known as left unilateral pneumonectomy (PNX), induces the expansion of mass and volume in the intact lobes of the remaining right lungs (Cowan and Crystal, 1975; Nolen-Walston et al., 2008). This regenerative process is driven by alveologenesis, a process dependent on proliferation of lung epithelial progenitor cells (Cardoso, 2001; Kotton and Fine, 2008; Rock and Hogan, 2011; Stripp and Reynolds, 2008), which comprise of subsets of alveolar epithelial cells (AECs) (Chapman et al., 2011; Liu et al., 2011) and presumably bronchioalveolar stem cells (BASCs) (Kim et al., 2005; Zhang et al., 2008). However, the precise mechanism(s) by which PNX initiates and sustains regenerative alveologenesis is unknown.
During lung development, the vascular plexus (capillary) sprouts in parallel with the alveolar budding (Metzger et al., 2008; White et al., 2007; Yamamoto et al., 2007), raising the possibility that regeneration of the pulmonary capillary plays a key role in orchestrating regenerative alveolarization. As a unique organ that facilitates gas exchange, the lung alveolus is highly vascularized, with pulmonary capillary endothelial cells (PCECs) lining all alveoli and residing in cellular proximity to AECs (Bhattacharya, 2005; Komarova and Malik, 2010; Petrache et al., 2005). The reconstitution of the alveolar-capillary interface is pivotal for pulmonary gas exchange function (Giordano et al., 2008; Huh et al., 2010; Petersen et al., 2010; Vaporciyan et al., 1993). However, the role of PCECs, as a specialized capillary vasculature in guiding alveolarization (Bhattacharya, 2005; DeLisser et al., 2006; Ding et al., 2003; Oh et al., 2007), in particular during regenerative alveolar remodeling (Metzger et al., 2008), remains unknown.
Capillary endothelial cells (ECs) that form the building blocks of the microvasculature of individual organs are endowed with unique organ-specific phenotypic and functional attributes (Aird, 2007; Carmeliet, 2005; Red-Horse et al., 2007; Ruoslahti and Rajotte, 2000). Capillary ECs are not solely passive conduits for the delivery of oxygen or nutrients, but also through elaboration of tissue-specific paracrine growth factors, defined as angiocrine factors (Butler et al., 2010a; Butler et al., 2010b), support organ development (Lammert et al., 2001; Matsumoto et al., 2001; Sakaguchi et al., 2008) and adult organ regeneration.
For example, sinusoidal endothelial cells (SECs) within liver and bone marrow comprise of phenotypically and functionally discreet populations of organ-specific endothelial cells. We have shown that after partial hepatectomy, liver SECs (LSECs) through a process of “inductive angiogenesis” that via angiocrine production of hepatocyte growth factor and Wnt2 stimulates hepatocyte proliferation (Ding et al., 2010). Subsequently, LSECs undergo “proliferative (sprouting) angiogenesis” to meet the incremental demand in the blood supply to the regenerating liver tissue. Similarly, after chemotherapy and irradiation activated bone marrow SECs reconstitute hematopoiesis by angiocrine expression of Notch ligands and IGFBPs (Butler et al., 2010a, Kobayashi et al., 2010). Conditional selective deletion of VEGF-A receptor-2 (VEGFR2) in either LSECs (Ding et al., 2010) or SECs (Hooper et al., 2009) of the adult mice by impairing the production of angiocrine factors inhibited liver or bone marrow regeneration, underscoring the physiological importance of endothelial-derived instructive signals in the adult organ regeneration. These findings have raised the possibility that PCECs also compose of a functionally unique population of specialized organ-specific ECs, which by production of specific angiocrine factors, could also induce regenerative alveolarization.
During development, PCECs undergo extensive sprouting angiogenesis to vascularize alveoli within the expanding lung tissue (Alvarez et al., 2008; Bhattacharya, 2005). In addition to their enduring capacity to undergo proliferative angiogenesis, PCECs by production of paracrine factors specify endoderm and mesoderm progenitors into primitive lung epithelial and vascular precursor cells (Del Moral et al., 2006; Healy et al., 2000; Shu et al., 2002; Voelkel et al., 2006; Yamamoto et al., 2007). These studies suggest that PCECs have the potential of producing as yet unrecognized angiocrine growth signals that support alveologenesis. Whether PCEC-derived instructive signals could also trigger regenerative alveolarization in the adult lungs has not been studied. Indeed, the paucity of mouse lung regenerative genetic models and lack of operational definition of PCECs have handicapped studies of PCECs in guiding alveolar regeneration in adult lungs.
In this study, we have defined the phenotypic and operational markers of mouse PCEC population as VE-cadherin+VEGFR2+FGFR1+CD34+ endothelial cells. Then, we have employed a unilateral PNX model to investigate the role of PCECs in supporting alveolar regeneration. In a variety of species, surgical resection of the left lung, which does not perturb the vascular integrity of the remaining right lobes, induces dramatic regrowth of these residual lobes. Here, we demonstrate that PNX through activation of VEGFR2 and FGFR1 induces PCECs of the remaining right lobe to produce the angiocrine factor, MMP14. In turn, MMP14 by unmasking cryptic epidermal growth factor (EGF)-like ligands promotes regenerative alveolarization through stimulating the proliferation of epithelial progenitor cells. These data suggest that PCECs could be therapeutically exploited for the treatment of lung disorders.
PNX induces expansion of epithelial progenitor cells
Within 15 days after PNX, there is a dramatic regeneration in both the mass and volume of the remaining lobes of right lungs (Fig. 1A, B). Lung epithelial progenitor cells, including subsets of BASC population identified phenotypically by Clara cell secreted protein (CCSP)+ and pro-surfactant protein C (SPC)+Sca-1+ (CCSP+SPC+Sca-1+ cells) and type II AECs (AECIIs) by SPC+E-cadherin+ cells have been shown to contribute to alveolar epithelialization (Beers and Morrisey, 2011). Therefore, to determine the contribution of epithelial progenitor cells to lung regeneration immediately after PNX, we introduced BrdU in the drinking water to detect slow cycling cells at day 1 to 7 after PNX. On day 3 after PNX, we observed amplification of BrdU+CCSP+ cells at bronchioalveolar duct junction (BADJ) (Fig. 1C). To track the expansion of BrdU+CCSP+ cells after PNX, we used reporter transgenic mice in which CCSP and SPC promoters drive the expression of YFP (CCSP-YFP and SPC-YFP mice) (Perl et al., 2002) (Fig. 1D, E). We performed polyvariate flow cytometric analysis of all mononuclear cell populations within the regenerating lungs on day 3 after PNX. The CCSP+BrdU+ cells localized to the BADJ region were found to be CCSP+SPC+Sca-1+VE-cadherinCD31 cells, a phenotypic signature observed on BASCs (Kim et al., 2005). At this early time point, we did not detect any significant proliferation of SPC+Sca-1CCSP AECIIs or VE-cadherin+CD31+ PCECs.Therefore, PNX induces expansion of slow cycling CCSP+SPC+Sca-1+ BASC-like cells in early phases of lung regeneration, when there is minimal proliferation of AECs and PCECs.
Figure 1
Figure 1
Unilateral left lung pneumonectomy (PNX) induces right lung regeneration and expansion of lung epithelial progenitors within 3 days post-PNX
PNX induces the expansion of PCECs and AECs co-localizing at the alveolar-capillary interface
To identify time points after PNX whereby AECs and PCECs undergo significant proliferation, we examined the kinetics of pulmonary incorporation of intraperitoneally injected BrdU, which revealed a global appearance of transit amplifying cells (TACs) in the remaining lung lobes that peaked at day 7 after PNX (Fig. 2A., Fig. S1). In the sham-operated mouse lung, there was little uptake of BrdU. To characterize the cell types among TACs on day 7 after PNX, we performed PNX on SPC-YFP reporter mice. There was increased proliferation of SPC+ cells that co-express pro-surfactant protein D (SPD) and E-cadherin, markers representing AECIIs (Beers et al., 1994) (Fig.2B). The remaining SPC TAC population consists of VE-cadherin+ PCECs and a small fraction of CCSP+ airway Clara cells (Rawlins et al., 2009). These data indicate that after PNX, BASC-like cells expand at early time point (day 3), while AECIIs proliferate at later time points.
Figure 2
Figure 2
At day 7 after PNX, expansion of AECs and PCECs sustain alveolar regeneration
Analysis of BrdU incorporation showed that on day 7 after PNX, proliferating VE-cadherin+ CD34+FGFR1+VEGFR2+CD45 PCEC saccounted for 7% of lung mononuclear cells (Fig.2C) that were detected in the cellular vicinity to SPC+ AECIIs (Fig. 2D). Using SPC+E-cadherin+ and VE-cadherin+CD34+ as operational markers for AECIIs and PCECs, respectively, we found that on day 15 after PNX there was a ~3-fold increase in the population of both AECIIs and PCECs (Fig. 2E). Therefore, after PNX the increase in lung mass and volume is primarily due to proliferation of epithelial progenitor cells and PCECs.
Sequential activation of VEGFR2 and FGFR1 in PCECs is essential for functional alveolar regeneration
One mechanism by which PNX initiates lung regeneration could be mediated through activation of PCECs to produce epithelial-active angiocrine factors. As VEGFR2, the principal tyrosine kinase receptor of VEGF-A, plays a critical role in induction of angiocrine factors (Ding et al., 2010; Hooper et al., 2009), we analyzed the activation of VEGFR2 in PCECs after PNX. Although VEGFR2 protein expression in PCECs is unaltered, after PNX there is a significant increase in the level of phosphorylated VEGFR2, indicating activation of this VEGF-A receptor (Fig. 3A).
Figure 3
Figure 3
Inducible deletion of Vegfr2 and partial knockdown of Fgfr1 in endothelial cells (EC) attenuates lung regeneration
Since FGFR1 is expressed in PCECs and can reciprocally modulate the expression and activation state of VEGFR2 to drive angiocrine factor production (Murakami et al., 2011; White et al., 2007), we also studied the expression of FGFR1 on PCECs. After PNX, FGFR1 protein was upregulated in a time-dependent manner. This finding suggests that while in early phases of lung regeneration, activation of VEGFR2 in PCECs plays a key role in inducing alveologenesis, at later phases, co-activation of FGFR1 might synergize with VEGFR2 to sustain epithelialization in the regenerating lungs.
To elucidate the endothelial-specific function of VEGFR2 and FGFR1 in the lungs, we employed an inducible knockout strategy to selectively delete Vegfr2 gene in adult mouse endothelial cells (Fig. 3B), using transgenic mice in which VE-cadherin promoter-drives the expression of tamoxifen-responsive Cre (VE-Cad-CreERT2) (Wang et al., 2010). Tamoxifen treatment selectively deletes Vegfr2 in endothelial cells (Vegfr2iΔEC/iΔEC mice). To account for the off-target toxicity by CreERT2, we used heterozygous Vegfr2 deficient (Vegfr2iΔEC/+) mice as control. We also generated mice in which both Vegfr2 and Fgfr1 were deleted in endothelial cells. However, these mice because of vascular instability could not tolerate surgical procedures. Therefore, we investigated the role of co-activation of FGFR1 and VEGFR2 in mediating alveologenesis by inducible Vegfr2 and partial Fgfr1 deletion in endothelial cells (Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice).
Before PNX, both Vegfr2iΔEC/iΔEC and Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice didn’t manifest alteration in lung mass and function (Fig. S2). By contrast, on day 3 after PNX, proliferation of CCSP+Sca1+ BASC-like cells was abolished in Vegfr2iΔEC/iΔEC mice (Fig. 3C, Fig. S2), while there was no further inhibition in expansion of these cells in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice after PNX. These data establish the critical role of VEGFR2 activation in supporting epithelial cell expansion at the early phases of lung regeneration.
We then studied the role of VEGFR2 and FGFR1 activation in the amplification of PCECs and AECIIs during lung regeneration. Co-staining of regenerating lungs with BrdU, VE-cadherin, and SPC at day 7 after PNX indicated that endothelial-specific knockdown of Vegfr2 in mice (Vegfr2iΔEC/iΔEC) abrogated propagation of both PCECs and AECIIs (Fig. 3D, E). Notably, endothelial-specific knockdown of Vegfr2 and Fgfr1 (Vegfr2iΔEC/iΔECFgfr1iΔEC/+) further abolished proliferation of PCECs and AECIIs at day 7 after PNX, suggesting that FGFR1 synergizes with VEGFR2 in stimulating PCECs to support AECII amplification and neo-angiogenesis.
Deletion of Vegfr2 & Fgfr1 in PCECs impairs restoration of alveolar structure and function
To determine whether co-activation of VEGFR2 and FGFR1 plays a role in improving lung function, we examined inspiratory volume and static compliance in Vegfr2iΔEC/iΔECFgfr1iΔEC/+and control mice before and after PNX. These parameters of pulmonary function provide physiologically relevant indexes of respiratory capacity of the lung. The restoration of pulmonary function after PNX was significantly impaired in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice at the time point when control mice exhibited complete recovery (Fig. 3F). Similarly, restoration of lung mass, volume, and cell expansion after PNX were all drastically impaired in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice (Fig. 3G). These data indicate that after PNX, non-proliferating VE-cadherin+ ECs induce the early expansion of BASC-like cells via VEGFR2 activation. At later phases of PNX, upregulation of FGFR1 in conjunction with VEGFR2 activate PCECs to promote regenerative epithelialization and vascular sprouting, restoring lung respiratory capacity (Fig. 3H). Thus, PCECs by producing angiocrine factors foster neo-alveolarization into functional respiratory alveolar units.
After PNX, MMP14 is specifically upregulated in PCECs and supports expansion of epithelial progenitor cells
To identify the inductive angiocrine cue that initiates epithelialization, we compared the gene expression profiles of the regenerative lungs by microarray (table S1), and found that among alveologenic factors, membrane-type 1 matrix metalloproteinase (MMP14) was specifically upregulated in the PCECs of wild-type, but not Vegfr2iΔEC/iΔEC or Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice (Fig. S3). Western analysis of MMP14 protein in the pneumonectomized lungs revealed its temporal upregulation that peaks at day 7 and levels off afterwards (Fig. 4A). Immunostaining and flow cytometric analysis illustrated the PCEC-specific localization of MMP14 after PNX, which was diminished in the Vegfr2iΔEC/iΔECFgfr1iΔEC/+ lungs (Fig. 4B, C). MMP14 was not upregulated in other vascular rich organs, including liver, heart, spleen and kidney (Fig. S3), indicating that after PNX MMP14 is selectively upregulated in the VEGFR2 and FGFR1 activated PCECs.
Figure 4
Figure 4
After PNX, MMP14 is specifically produced by PCECs and induces formation of alveolar-capillary-like sacs in 3-dimensional coculture with activated ECs
To define the mechanism by which angiocrine expression of MMP14 promotes the propagation of epithelial progenitor cells, we used endothelial coculture with AECIIs and BASCs isolated from SPC-YFP and CCSP-YFP mice, respectively. YFP expression was utilized to track their fate during coculture period. Since MMP14 was upregulated in primary MAPKinase-activated ECs (MAPK-ECs) (Kobayashi et al., 2010), we cocultured MAPK-ECs with AECIIs/BASCs in 3-dimensional (3D) spheroid assay. Coculture with MAPK-ECs led to the most significant expansion of SPC+ AECIIs and CCSP+Sca-1+CD31 BASCs (Fig. 4D–G, Fig. S3), resulting in formation of 3D spheroid structures that resemble the capillary-alveolar sacs. MMP14 knockdown in MAPK-ECs abolished expansion of BACSs and AECIIs (Fig. 4D, F). Conditioned medium (CM) from MAPK-ECs showed negligible effect in promoting AECII and BASC propagation, underscoring the requirement for cell-cell contact between endothelial coculture with epithelial cells (Fig. 4E, G). Therefore, resection of the left lung activates VEGFR2 and FGFR1 on PCECs triggering MMP14 production, which in turn stimulates propagation of epithelial progenitor cells.
After PNX, MMP14 inhibition abrogates the reconstitution of AECs, but not PCECs
To determine the physiological significance of MMP14 in modulating alveologenesis, we injected WT mice with neutralizing monoclonal antibody (mAb) to MMP14. After PNX, mAb to MMP14 blunted the increase of mass and volume of the remaining lungs in WT but not Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice, indicating that MMP14 is primarily derived from VEGFR2 and FGFR1 activated PCECs (Fig. 5A, Fig. S4). MMP14 inhibition blocked expansion of E-cadherin+ AECs without impairing reconstitution of the VE-cadherin+ PCECs (Fig. 5B). The mismatched expansion of AECs and PCECs after MMP14 inhibition indicates that MMP14 primarily induces propagation of AECs (inductive angiogenesis), rather than promoting PCEC proliferation (proliferative angiogenesis).
Figure 5
Figure 5
PCEC-derived MMP14 supports regenerative alveolarization
The reduced expansion of AECs, but not PCECs, by MMP14 neutralization was further demonstrated by flow cytometric analysis (Fig. 5C, D). Furthermore, in mice injected with mAb to MMP14, morphological examination revealed inhibition in alveolar regrowth, as evidenced by decrease in alveolar number and increase in alveolar size measured by mean alveolar intercept (Fig. 5E, F). Collagen synthesis remained unchanged in mice injected with mAb to MMP14 (Fig. S4). Therefore, PCEC-derived MMP14 stimulates neoalveolarization, forming alveolar sacs reminiscent of normal adult alveoli.
MMP14 stimulates alveologenesis via unmasking cryptic EGF-like ligands
We next sought to unravel the mechanism by which MMP14 regulates regenerative alveolarization. MMP14 has been shown to shed the ectodomain of heparin binding EGF-like growth factor (HB-EGF) (Koshikawa et al., 2010; Stratman et al., 2011). In addition, MMP14 cleaves laminin5 γ2 chain, which generates the EGF-like fragment that activates EGF receptor (EGFR) (Schenk et al., 2003). We found that at day 3 and 7 after PNX, HB-EGF in the bronchioalveolar lavage fluid (BALF) is increased (Fig. 6A, B). The cleaved fragment of laminin5 γ2 chain appeared in the regenerating lungs at day 7 after PNX (Fig. 6C, Fig. S5). However, the level of these EGFR ligands was decreased in both control mice treated with mAb to MMP14 and Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice, in which there is diminished expression of MMP14. Knockdown of MMP14 in MAPK-ECs in the 3D endothelial coculture with BASCs and AECs also abrogated the release of EGFR ligands into the culture supernatants (Fig. S5). Hence, after PNX, activation of VEGFR2 and FGFR1 in PCECs leads to the angiocrine production of MMP14, which in turn unmasks cryptic EGFR ligands stimulating alveolar regeneration.
Figure 6
Figure 6
Angiocrine production of MMP14 induces alveologenesis by shedding EGF-like ectodomains from HB-EGF and laminin5 γ2 chain, activating EGF receptor (EGFR)
EGF restores alveologenesis in Vegfr2iΔEC/iΔEC Fgfr1iΔEC/+ mice
Both shedded HB-EGF and cleaved laminin5 γ2 chain induce activation of EGFR (Schenk et al., 2003) that is indispensible for epithelial proliferation and morphogenesis (Knox et al., 2010; Maretzky et al., 2011). Our findings suggest that after PNX, impaired lung alveolarization in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice is due to a decrease in the bioavailability of EGFR ligands. This raises the possibility that injection of EGF might restore alveolarization in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice by enhancing epithelialization. Thus, we tested the effect of recombinant EGF in restoring the defective alveolar regeneration in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice. Intravenous injection of EGF restored lung mass and volume in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice and in mice treated with mAb to MMP14 (Fig. 6D, Fig. S5). Compared to the intravenous injection of EGF, direct introduction of EGF into bronchioalveolar epithelium via intratracheal injection showed a similar effect in rescuing alveolar regeneration (Fig. S5). Therefore, the defective regeneration of AECs in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice (Fig. 3) is due to diminished MMP14 production by PCECs that leads to attenuation in the bioavailability of EGFR ligands.
Notably, in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice injected with EGF, there was a profound enhancement in the cellular association of E-cadherin+ AECs with VE-cadherin+ PCECs (Fig. 6E, Fig. S5) restoring pulmonary function (Fig. 6F). EGF injection into Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice stimulated regeneration of AECs, but not PCECs (Fig. S5), suggesting that EGF has a minor effect in stimulating sprouting angiogenesis, while being more effective in inducing epithelialization. To test this hypothesis, we analyzed the effect of EGF administration on cell amplification at day 7 after PNX. Injection of EGF led to enhanced EGFR phosphorylation in the Vegfr2iΔEC/iΔECFgfr1iΔEC/+ lung (Fig. 6G). BrdU incorporation analysis revealed that EGF restored the proliferation of AECIIs, but not PCECs in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice (Fig. 6H, I). This finding indicates that the alveologenic defect in Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice is due to the impaired generation of the epithelial-active angiocrine factors, rather than a compromise in vascular perfusion to the regenerating lung.
Transplantation of WT PCECs restores alveolarization in Vegfr2iΔEC/iΔEC Fgfr1iΔEC/+ mice
In our study, the tamoxifen-responsive Cre driven by pan-endothelial VE-cadherin could delete Vegfr2 and Fgfr1 in endothelial cells (ECs) of other vascular beds. Thus, to investigate the contribution of activated PCECs to specifically drive lung regeneration, we designed a lung endothelial cell (EC) transplantation model. ECs were purified from either lung or liver of the WT littermate pneumonectomized mice and infused into the jugular vein of Vegfr2iΔEC/iΔEC and Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice (Fig. 7A). Plasma was also collected from pneumonectomized WT mice and injected into the recipient knockout mice to interrogate the contribution of systemic soluble growth factors to lung regeneration after PNX.
Figure 7
Figure 7
Transplantation of wild type PCECs restores the defective alveolar regeneration in the mice deficient in endothelial Vegfr2 and Fgfr1
Transplanted GFP+ ECs incorporated into ~26% of the pulmonary capillaries of the recipient mice (Fig 7B, Fig. S6). Importantly, the engrafted ECs obtained from the pneumonectomized lungs, but not the liver, restored the amplification of epithelial cells (Fig. 7C–F, Fig. S6). Proliferating BrdU+CCSP+ BASC-like cells and BrdU+SPC+ AECIIs were positioned in the proximity of the transplanted GFP+ PCECs, indicating that the inductive signals derived from the infused WT PCECs restore lung regeneration. Accordingly, the pulmonary function was also improved by transplantation of PCECs but not injection of plasma procured from pneumonectomized WT mice (Fig. 7G). Therefore, PNX induces a lung-specific activation of PCECs to elaborate angiocrine factors that support regenerative lung alveolarization (Fig. 7H).
After PNX, activation of PCECs supports expansion of epithelial progenitor cells
We have employed PNX-induced alveolar regeneration model, endothelial-specific knock down of Vegfr2 and Fgfr1, and a 3D endothelial-epithelial coculture model, to establish the essential role of the PCECs in promoting regenerative alveologenesis. We have uncovered the angiocrine role of MMP14, which by shedding HB-EGF and generating EGF-like fragment from laminin5 γ2 chain, stimulates the amplification of lung epithelial progenitor cells, including subsets of BASCs and AECs, supporting alveolarization. The role of MMP14/EGFR activation in promoting alveologenesis was borne out in studies in which EGF administration into Vegfr2iΔEC/iΔECFgfr1iΔEC/+ mice restored alveolar regeneration after PNX. Moreover, we established a lung PCEC transplantation model to define the essential role of functionally incorporated PCECs in restoring epithelialization in mice with impaired capacity to undergo neoalveolarization. Hence, we have demonstrated that after PNX, PCECs orchestrate regenerative alveolarization by formation of new vessels as well as through instructive production of epithelial-active angiocrine factors.
PNX induced alveolar regeneration via amplification of epithelial progenitor cells. At early phases (day 0–3), PNX induces expansion of CCSP+SPC+Sca-1+CD31VE-cadherin BASC-like cells localized at BADJ. At the later phases of lung regeneration (day 7–15 post PNX) SPC+E-cadherin+ AECIIs and PCECs expand, re-establishing functional alveolar-capillary units. Upon MMP14 inhibition, the loss of alveolar coverage of not only cuboidal SPC+E-cadherin+, but also squamous SPCE-cadherin+ AEC implicates that transiently amplified SPC+E-cadherin+ AECIIs generate SPCE-cadherin+ type I AECs (Beers and Morrisey, 2011; Morrisey and Hogan, 2010; Rock and Hogan, 2011), leading to full reconstitution of alveolar surface after PNX. Therefore, activated PCECs drive regeneration of specialized lung epithelial cells that collectively reconstitute functional alveolar-capillary sacs.
PCECs initiate alveologenesis through MMP14-mediated release of EGF-like ligands
We show that PCEC-derived MMP14 is required for the expansion of epithelial cells as well as restoration of alveolar structure and pulmonary function. In the developing mouse fetal lung, MMP14 regulates alveolar formation (Atkinson et al., 2005; Irie et al., 2005; Oblander et al., 2005), presumably by stimulating epithelial proliferation and migration (Chun et al., 2006; Hiraoka et al., 1998; Koshikawa et al., 2010; Stratman et al., 2009). Postnatally, MMP14 deficient mice exhibit defective alveolarization and abnormal sacculation, manifested by impaired vascular integration with AECs. This suggests that MMP14 plays a critical role in mediating alveolar-capillary crosstalk by as yet undefined mechanism (Li et al., 2002; Morris et al., 2003; Page-McCaw et al., 2007; Yana et al., 2007). Here, we show that after PNX, inhibition of MMP14 interfered with the alveolar regrowth but not endothelial proliferation, leading to enlarged alveolar size. This suggests that MMP14 is dispensable for proliferative angiogenesis, but plays a key role in inducing regenerative alveolarization. The mechanism by which MMP14 modulate alveologenesis is mediated by shedding of HB-EGF into alveolar space and generating EGF-like fragment from laminin5 γ2 chain. Subsequently, increase in the bioavailable EGFR-ligands fosters regeneration of epithelial progenitors. In this regard, MMP14 performs as a PCEC-specific angiocrine cue that drives regenerative alveolarization.
PCEC-specific induction of MMP14 defines unique functional signature of lung vasculature
Each organ is vascularized by specialized population of capillary endothelial cells identified by unique phenotypic, functional and structural attributes (Butler et al., 2010a; Butler et al., 2010b). We have shown that bone marrow and liver SECs (Butler et al., 2010a; Butler et al., 2010b), which are demarcated by VEGFR2+VEGFR3+VE-cadherin+ vessels, express defined set of angiocrine factors driving organ regeneration. After partial hepatectomy, VEGFR2 and Id1 activated liver SECs produce HGF and WNT2 (Ding et al., 2010), while bone marrow VEGFR2 activated SECs express Notchligands and IGFBPs (Butler et al., 2010a; Butler et al., 2010b) to induce reconstitution of hepatocytes and hematopoietic cells, respectively.
Similarly, PCECs have distinct phenotypic signature and could be identified as VEGFR2+FGFR1+CD34+VE-cadherin+ vessels. Remarkably, after PNX, the production of MMP14 is restricted to VEGFR2 and FGFR1 activated PCECs but not other vascular rich organs, such as liver, spleen, heart and kidneys, highlighting a unique functional signature of PCECs in alveolar regeneration. The negligible effect of plasma obtained from pneumonectomized WT mice in restoring alveologenesis also demonstrated the minimal contribution of systemic soluble growth factor(s) from non-pulmonary vasculature in mediating alveologenesis. These data clearly set forth the notion that PNX turns on a PCEC-specific program to promote alveolar regeneration.
The mechanism by which PNX specifically upregulates MMP14 in PCECs could be regulated by microenvironmental cues and/or unique inherent programming of PCECs. For example, surgical removal of left lung lobe leads to local activation of PCECs in the remaining right lungs, without affecting other vascular beds (Fig. 1A). Alternatively, PCECs, but not other organ-specific capillaries, may be developmentally predetermined to express MMP14 in response to regenerative signals. Notwithstanding to the potential developmental or microenvironmental cues that endow PCECs with their unique functional attributes, our findings consolidate the concept that angiocrine heterogeneity plays a key role in orchestrating organ regeneration.
Sequential activation of VEGFR2 and FGFR1 primes PCECs during alveolar regeneration
The mechanism by which PCECs are induced to express MMP14 after PNX is mediated by hierarchical activation and upregulation of VEGFR2 and FGFR1. At the early phase of PNX, expansion of BASC-like cells is largely dependent on the activation of VEGFR2 in PCECs, which causes upregulation of MMP14 without inducing endothelial proliferation. In contrast to the early activation and stable expression of VEGFR2, FGFR1 expression level is induced thereafter peaking day 7 after PNX. We show that FGFR1 synergizes with VEGFR2 in augmenting MMP14 generation thereby sustaining alveolar regeneration. Therefore, sequential activation of VEGFR2 and FGFR1 in PCECs induces MMP14 production, fostering regeneration of the functional alveolar-capillary units.
PCEC transplantation and administration of PCEC-derived angiocrine factors offers new approaches for treatment of respiratory diseases
The development of therapeutic strategies to repair the respiratory capacity in patients with pulmonary disorders, is handicapped by lack of understanding of lung regeneration mechanisms (Jiang et al., 2005; Kajstura et al., 2011; Matthay and Zemans, 2011; Morris et al., 2003; Petrache et al., 2005). We have set forth the concept that after PNX activated PCECs play a central role in restoring respiratory capacity, as measured by inspiratory volume and static compliance. Notably, administration of EGF or transplantation of activated WT PCECs improved respiratory function in mice. It is plausible that transplantation of properly activated PCECs or injection of lung-specific angiocrine mediators could improve lung function in subset of patients with pulmonary disorders.
In conclusion, we have introduced the concept that PCECs not only form passive vascular conduits to fulfil the metabolic demands of the regenerating lungs, but also by relaying inductive angiocrine growth signals, such as MMP14, orchestrates regenerative alveologenesis. Therefore, selective activation of VEGFR2 and FGFR1 or increase in the bioavailability of MMP14 in PCECs might facilitate lung alveolarization thereby improving hypoxemia in patients with debilitating lung diseases.
Transgenic reporter and gene targeted animals
C57BL/6J mice were obtained from Jackson Laboratories (Bar Harbor, ME). Generation of endothelial-specific Vegfr2 and Fgfr1 inducible knockout mice was carried out as previously described (Hooper et al., 2009; Wang et al., 2010). Briefly, Vegfr2loxP/loxP mice were bred with VE-cadherin-CreERT2 transgenic mice to establish the VE-cadherin-CreERT2+Vegfr2LoxP/LoxP and VE-cadherin-CreERT2+Vegfr2LoxP/+ mice. Fgfr1loxP/loxP mice were further crossed with VE-cadherin-CreERT2+Vegfr2loxP/loxP line to generate compound mutant of VE-cadherin-CreERT2+Vegfr2loxP/loxPFgfr1loxP/+ mice. These mice were i.p. treated with tamoxifen at a dose of 250 mg/kg in sunflower oil for 6 days (interrupted for 3 days after the third dose), leading to endothelial-specific deletion of Vegfr2 and Fgfr1. After 3 weeks of tamoxifen treatment, knock down of the Vegfr2 and Fgfr1 in PCECs was quantified by quantitative PCR and immunostaining.
Mice bearing SPC and CCSP promoter-driven rtTA (SPC-rtTA, CCSP-rtTA) and (tetO)7CMV-driven cre ((tetO)7-cre) (Perl et al., 2002) crossed with Rosa26R–eYFP mice carrying transgene constructs in which YFP expression is blocked by upstream loxP-flanked stop codon (Jackson Labs), resulting in SPC or CCSP-rtTA/(tetO)7-cre/Rosa26R–eYFP mice. Treatment of these mice with tetracycline generated SPC-YFP and CCSP-YFP reporter mice. All animal experiments were carried out under guidelines set by Institutional Animal Care and Use Committee, using age/weight/strain matched littermate animals.
Pneumonectomy (PNX) Model and physiological measurements of lung mechanics
PNX procedure was adapted as described (Nolen-Walston et al., 2008). Briefly, mice were anesthetized and orotracheal intubation was performed. Mice were mechanically ventilated (Minivent 845) at 150– 200 tidal breaths of 0.3 ml of room air per minute. The skin and pleura muscle were incised between the 5th and 6th intercostal ribs, and the left lung lobe was gently lifted while a 5-0 silk suture was tied around the hilum. After the left lobe distal to the suture was resected, the chest wall was reapproximated, and the skin was closed. Mice were extubated at the onset of vigorous spontaneous breathing. Sham mice underwent thoracotomy without lobe resection. At different time points after PNX, lung mass and volume were measured (Nolen-Walston et al., 2008) and normalized to body weight. Isolation of PCECs and examination of phosphorylation and protein level of VEGFR2 and FGFR1 was carried out (Murakami et al., 2011). Briefly, perfused mouse lung was digested with collagenase/dispase and dispersed mechanically into single-cell suspension. PCECs were purified from cell suspension using sequential positive selections with anti-CD31, ICAM-2 and VE-cadherin antibodies conjugated to Dynabeads (Invitrogen). Hematopoietic cells are further excluded by a negative depletion with anti-CD45 Dynabeads.
Inspiratory capacity was determined between the plateau pressure measurements of the total lung capacity (TLC) and functional residual volume (FRC) using the Flexivent software (Scireq). Static compliance was determined from pressure-volume curves that were generated by sequential delivery of air between FRC and TLC and calculated during the expiratory phase of the pressure-volume loop.
Immunofluorescence (IF) and flow cytometric analysis
Mice were subjected to PNX or sham operation, and tissues were cryoprotected. For IF studies, the lung sections were incubated in primary Abs: anti-VE-cadherin Ab (2 µg/ml, R&D), anti-CD34 mAb (5µg/ml, BD), anti-E-cadherin (2µg/ml, eBiosciences), and anti-SPC polyclonal Ab (5 µg/ml, Abcam). After incubation in fluorophore-conjugated secondary antibodies (2.5 µg/ml, Jackson Immuno Research). Lung cell proliferation in vivo was measured by BrdU uptake. Briefly, mice received injection of BrdU (Sigma) intraperitoneally 60 min before death (50 mg/kg). To track proliferating BASC-like cells, BrdU (1 mg/ml) was introduced in drinking water on day 0–7 after PNX. Cryosections were stained using the BrdU Detection System, and IF images were captured on AxioVert LSM710 confocal microscope (Zeiss). Lung morphological analysis of alveolar number and mean linear intercept was performed (Fehrenbach et al., 2008).
Total lung mononuclear cells were isolated (Bortnick et al., 2003; Kim et al., 2005) and analyzed on LSRII-SORP (BD). Conjugation of purified mAbs, exclusion of cell doublets and procession of data were performed (Ding et al., 2010). Antibodies used: VE-cadherin (BV13, ImClone); VEGFR2 (DC101, ImClone); CD45 (30-F11, BD), and CD34 (14–0341, eBioscience). AECs and PCECs were quantified by staining with conjugated antibodies against SPC + E-cadherin and VE-cadherin + CD34, respectively.
Pharmacological administration of EGF and neutralizing monoclonal antibody (mAb) to MMP14
Mice were injected with mAb to mouse MMP14 (MMP14 mAb, 50 mg/kg, Abcam) and IgG control 12 hours before PNX and every other day. To determine the role of recombinant EGF in alveolar regeneration, mice were intravenously injected with 500 µg/kg recombinant mouse EGF (Abcam) on daily basis after PNX for 14 days. Mice were also intratracheally injected with 100 µg/kg EGF (in 50 µl volume) every other day to examine the local effect of EGF.
Determination of AECII and BASC proliferation in coculture with primary ECs
MAPkinase- and Akt- activated primary endothelial cells (MAPK-ECs, Akt-ECs) (Kobayashi et al., 2010) were cocultured with AECIIs and BASCs isolated from SPC and CCSP-YFP mice (Bortnick et al., 2003; Kim et al., 2005). Mmp14 or scrambled shRNA was used to selectively knockdown Mmp14 in MAPK-ECs or AECs (Ding et al., 2010). For co-culture studies, 50,000 isolated SPC+ AECIIs and 2,000 BASCs were plated in non-adherent dish, seeded with 10-fold more MAPK-ECs. Conditioned medium from MAPK-ECs was added to AECs (Ding et al., 2010). After coculture, AECIIs and BASCs were quantified by flow cytometric analysis and comparing the number of retrieved cells to initially seeded number.
Quantitative PCR analysis, ELISA, and immunoblot
At Day 7 after PNX, total RNA was isolated from the lung of Vegfr2iΔEC/iΔECFgfr1iΔEC/+ and Vegfr2iΔEC/+ mice using RNeasy (Qiagen) and converted to cDNA using Superscript II (Invitrogen). qPCR was carried out using Taqman gene expression systems for mouse MMP14 (Applied Biosystems). Bronchioalveolar lavage fluid (BALF) and lung total protein were obtained (Kim et al., 2005), and concentration of HB-EGF in BALF was examined by sandwich ELISA and immunoblot using anti-HB-EGF antibodies (Santa Cruz), and the cleavage of laminin5 γ2 chain in the lung was tested with antibody against mouse γ2 chain (Santa Cruz).
Data Analysis
All data are presented as the Mean ± sem of at least three separate experiments. Differences between groups were tested for statistical significance using Student’s t-test or analysis of variance (ANOVA). Statistical significance was set at P < 0.05.
Supplementary Material
01
02
Acknowledgments
B.-S. D. is a Druckenmiller Fellow of New York Stem Cell Foundation. S.R. is supported by the Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board and the New York State Department of Health grants (C024180, C026438, C026878); National Heart Lung and Blood Institute; Qatar National Priorities Research Foundation NPRP08-663-3-140; Anbinder and Newmans Own Foundation. T.N.S is supported by Takeda Science Foundation, The Uehara Memorial Foundation, JSPS (Kiban S). M.S. is supported by R01 HL53793. VE-cadherin-ERT2 mice were gift from Dr. Ralf H. Adams (Max Planck Institute). SPC and CCSP-rtTA and (tetO)-cre mice were generously provided by Drs. Jeffrey A. Whitsett and Anne-Karina T. Perl (Cincinnati Children's Hospital Medical Centre). Fgfr1loxP/loxP mice were kindly offered by Drs. Michael Simons and Masahiro Murakami (Yale University). The authors are grateful to Ms. Biin Sung for her assistance in lung mechanics measurement.
Footnotes
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  • Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158–173. [PubMed]
  • Alvarez DF, Huang L, King JA, ElZarrad MK, Yoder MC, Stevens T. Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity. Am J Physiol Lung Cell Mol Physiol. 2008;294:L419–430. [PubMed]
  • Atkinson JJ, Holmbeck K, Yamada S, Birkedal-Hansen H, Parks WC, Senior RM. Membrane-type 1 matrix metalloproteinase is required for normal alveolar development. Dev Dyn. 2005;232:1079–1090. [PubMed]
  • Beers MF, Kim CY, Dodia C, Fisher AB. Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies. J Biol Chem. 1994;269:20318–20328. [PubMed]
  • Beers MF, Morrisey EE. The three R's of lung health and disease: repair,remodeling, and regeneration. J Clin Invest. 2011;121:2065–2073. [PMC free article] [PubMed]
  • Bhattacharya J. Alveolocapillary cross-talk: Giles F. Filley lecture. Chest. 2005;128:553S–555S. [PubMed]
  • Bortnick AE, Favari E, Tao JQ, Francone OL, Reilly M, Zhang Y, Rothblat GH, Bates SR. Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. Am J Physiol Lung Cell Mol Physiol. 2003;285:L869–878. [PubMed]
  • Butler JM, Kobayashi H, Rafii S. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat Rev Cancer. 2010a;10:138–146. [PMC free article] [PubMed]
  • Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT, Seandel M, Shido K, White IA, Kobayashi M, et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell. 2010b;6:251–264. [PMC free article] [PubMed]
  • Cardoso WV. Molecular regulation of lung development. Annu Rev Physiol. 2001;63:471–494. [PubMed]
  • Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438:932–936. [PubMed]
  • Chapman HA. Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol. 2011;73:413–435. [PubMed]
  • Chapman HA, Li X, Alexander JP, Brumwell A, Lorizio W, Tan K, Sonnenberg A, Wei Y, Vu TH. Integrin alpha6beta4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest. 2011;121:2855–2862. [PMC free article] [PubMed]
  • Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell. 2006;125:577–591. [PubMed]
  • Cowan MJ, Crystal RG. Lung growth after unilateral pneumonectomy: quantitation of collagen synthesis and content. Am Rev Respir Dis. 1975;111:267–277. [PubMed]
  • Del Moral PM, Sala FG, Tefft D, Shi W, Keshet E, Bellusci S, Warburton D. VEGF-A signaling through Flk-1 is a critical facilitator of early embryonic lung epithelial to endothelial crosstalk and branching morphogenesis. Dev Biol. 2006;290:177–188. [PubMed]
  • DeLisser HM, Helmke BP, Cao G, Egan PM, Taichman D, Fehrenbach M, Zaman A, Cui Z, Mohan GS, Baldwin HS, et al. Loss of PECAM-1 function impairs alveolarization. J Biol Chem. 2006;281:8724–8731. [PubMed]
  • Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature. 2010;468:310–315. [PMC free article] [PubMed]
  • Ding BS, Zhou YJ, Chen XY, Zhang J, Zhang PX, Sun ZY, Tan XY, Liu JN. Lung endothelium targeting for pulmonary embolism thrombolysis. Circulation. 2003;108:2892–2898. [PubMed]
  • Fehrenbach H, Voswinckel R, Michl V, Mehling T, Fehrenbach A, Seeger W, Nyengaard JR. Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice. Eur Respir J. 2008;31:515–522. [PubMed]
  • Giordano RJ, Lahdenranta J, Zhen L, Chukwueke U, Petrache I, Langley RR, Fidler IJ, Pasqualini R, Tuder RM, Arap W. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem. 2008;283:29447–29460. [PMC free article] [PubMed]
  • Healy AM, Morgenthau L, Zhu X, Farber HW, Cardoso WV. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung. Dev Dyn. 2000;219:341–352. [PubMed]
  • Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 1998;95:365–377. [PubMed]
  • Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M, Kopp HG, Shido K, Petit I, Yanger K, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell. 2009;4:263–274. [PMC free article] [PubMed]
  • Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. [PubMed]
  • Irie K, Komori K, Seiki M, Tsuruga E, Sakakura Y, Kaku T, Yajima T. Impaired alveolization in mice deficient in membrane-type matrix metalloproteinase 1 (MT1-MMP) Med Mol Morphol. 2005;38:43–46. [PubMed]
  • Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11:1173–1179. [PubMed]
  • Kajstura J, Rota M, Hall SR, Hosoda T, D'Amario D, Sanada F, Zheng H, Ogorek B, Rondon-Clavo C, Ferreira-Martins J, et al. Evidence for human lung stem cells. N Engl J Med. 2011;364:1795–1806. [PMC free article] [PubMed]
  • Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell. 2005;121:823–835. [PubMed]
  • Knox SM, Lombaert IM, Reed X, Vitale-Cross L, Gutkind JS, Hoffman MP. Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis. Science. 2010;329:1645–1647. [PMC free article] [PubMed]
  • Kobayashi H, Butler JM, O'Donnell R, Kobayashi M, Ding BS, Bonner B, Chiu VK, Nolan DJ, Shido K, Benjamin L, et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol. 2010;12:1046–1056. [PMC free article] [PubMed]
  • Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463–493. [PubMed]
  • Koshikawa N, Mizushima H, Minegishi T, Iwamoto R, Mekada E, Seiki M. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor. Cancer Res. 2010;70:6093–6103. [PubMed]
  • Kotton DN, Fine A. Lung stem cells. Cell and tissue research. 2008;331:145–156. [PubMed]
  • Li Q, Park PW, Wilson CL, Parks WC. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002;111:635–646. [PubMed]
  • Liu Y, Sadikot RT, Adami GR, Kalinichenko VV, Pendyala S, Natarajan V, Zhao YY, Malik AB. FoxM1 mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosa. J Exp Med. 2011;208:1473–1484. [PMC free article] [PubMed]
  • Maretzky T, Evers A, Zhou W, Swendeman SL, Wong PM, Rafii S, Reiss K, Blobel CP. Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. Nat Commun. 2011;2:229. [PMC free article] [PubMed]
  • Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011;6:147–163. [PMC free article] [PubMed]
  • Metzger RJ, Klein OD, Martin GR, Krasnow MA. The branching programme of mouse lung development. Nature. 2008;453:745–750. [PMC free article] [PubMed]
  • Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature. 2003;422:169–173. [PubMed]
  • Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell. 2010;18:8–23. [PubMed]
  • Murakami M, Nguyen LT, Hatanaka K, Schachterle W, Chen PY, Zhuang ZW, Black BL, Simons M. FGF-dependent regulation of VEGF receptor 2 expression in mice. J Clin Invest. 2011;121 [PMC free article] [PubMed]
  • Nolen-Walston RD, Kim CF, Mazan MR, Ingenito EP, Gruntman AM, Tsai L, Boston R, Woolfenden AE, Jacks T, Hoffman AM. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1158–1165. [PMC free article] [PubMed]
  • Oblander SA, Zhou Z, Galvez BG, Starcher B, Shannon JM, Durbeej M, Arroyo AG, Tryggvason K, Apte SS. Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev Biol. 2005;277:255–269. [PubMed]
  • Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, et al. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol. 2007;25:327–337. [PMC free article] [PubMed]
  • Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221–233. [PMC free article] [PubMed]
  • Perl AK, Wert SE, Nagy A, Lobe CG, Whitsett JA. Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci U S A. 2002;99:10482–10487. [PubMed]
  • Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, et al. Tissue-engineered lungs for in vivo implantation. Science. 2010;329:538–541. [PubMed]
  • Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11:491–498. [PMC free article] [PubMed]
  • Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H, Wang F, Hogan BL. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell. 2009;4:525–534. [PMC free article] [PubMed]
  • Red-Horse K, Crawford Y, Shojaei F, Ferrara N. Endothelium-microenvironment interactions in the developing embryo and in the adult. Dev Cell. 2007;12:181–194. [PubMed]
  • Rock JR, Hogan BL. Epithelial Progenitor Cells in Lung Development, Maintenance, Repair, and Disease. Annu Rev Cell Dev Biol. 2011 [PubMed]
  • Ruoslahti E, Rajotte D. An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol. 2000;18:813–827. [PubMed]
  • Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol. 2003;161:197–209. [PMC free article] [PubMed]
  • Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev. 2003;83:673–686. [PubMed]
  • Shu W, Jiang YQ, Lu MM, Morrisey EE. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development. 2002;129:4831–4842. [PubMed]
  • Stratman AN, Saunders WB, Sacharidou A, Koh W, Fisher KE, Zawieja DC, Davis MJ, Davis GE. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood. 2009;114:237–247. [PubMed]
  • Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood. 2011;116:4720–4730. [PubMed]
  • Stripp BR, Reynolds SD. Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc. 2008;5:328–333. [PMC free article] [PubMed]
  • Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML, Ward PA, Albelda SM. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 1993;262:1580–1582. [PubMed]
  • Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol. 2006;290:L209–221. [PubMed]
  • Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A, Adams S, Davy A, Deutsch U, Luthi U, et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature. 2010;465:483–486. [PubMed]
  • Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O, De Langhe S, Kemp PJ, Riccardi D, Torday J, et al. Lung organogenesis. Curr Top Dev Biol. 2010;90:73–158. [PMC free article] [PubMed]
  • White AC, Lavine KJ, Ornitz DM. FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network. Development. 2007;134:3743–3752. [PMC free article] [PubMed]
  • Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010;61:105–119. [PubMed]
  • Yamamoto H, Yun EJ, Gerber HP, Ferrara N, Whitsett JA, Vu TH. Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol. 2007;308:44–53. [PubMed]
  • Yana I, Sagara H, Takaki S, Takatsu K, Nakamura K, Nakao K, Katsuki M, Taniguchi S, Aoki T, Sato H, et al. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J Cell Sci. 2007;120:1607–1614. [PubMed]
  • Zhang Y, Goss AM, Cohen ED, Kadzik R, Lepore JJ, Muthukumaraswamy K, Yang J, DeMayo FJ, Whitsett JA, Parmacek MS, et al. A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration. Nat Genet. 2008;40:862–870. [PMC free article] [PubMed]